Abstract
Preoperative autologous donation (PAD) is a widely recognized blood conservation strategy that can be defined as the procurement of a specified portion of a patient’s blood preoperatively for later use during the intraoperative and postoperative periods. Its appropriate application leads to a direct reduction in homologous transfusion requirement via a unit-for-unit substitution of autologous for homologous blood. Although there was a gradual increase in the use of PAD in cardiac and general surgery from the early 1960s onward, PAD did not achieve a significant role in perioperative transfusion medicine until the advent of AIDS in the early 1980s and the greater transfusion risk awareness that accompanied this disease. But despite educational efforts aimed at increasing physician-patient awareness of the benefits of PAD, it has remained a relatively underutilized resource. Issues that have hampered its more widespread application in cardiac surgery include those of efficacy, safety, and more recently, cost-effectiveness. But perhaps the most important factor limiting the use of PAD in cardiac surgery is the changing character of the cardiac surgical patient pool. The increasingly acute nature of most cardiac operative interventions in the 1990s, in older and sicker patients, severely limits the preoperative time that is available to optimally perform PAD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blundell J. Successful case of transfusion. Lancet 1829;431–432.
Pineda AA. Review of the history. In: Taswell HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991;1–21.
Grant FC. Autotransfusion. Ann Surg 1921;74(8):253.
Langston H, Milles G, Dalessandro W. Further experiences with autologous blood transfusions. Ann Surg 1963;158:333–336.
Milles G, Langston HT, Dalessandro W. Experiences with autotransfusion. Surg Gynecol Obstet 1962;Dec:689–694.
Kay LA. The need for autologous blood transfusion. Br Med J 1987;294:137–139.
Toy PT, Stehling LC, Strauss RG, et al. Underutilization of autologous blood donation among eligible elective surgical patients. Am J Surg 1986;152:483–486.
Amman AJ, Wara DW, Dritz S, et al. Acquired immunodeficiency in an infant. Possible transmission by means of blood products. Lancet 1983;1:956–985.
Joint statement on acquired immune deficiency syndrome (AIDS) related to transfusion. Transfusion. 1983; 23: 87 – 88.
American Medical Association Council on Scientific Affairs. Autologous blood transfusions. JAMA 1986;256(17):2378–2380.
Toy PT, McVay PA, Strauss RG, et al. Improvement in appropriate autologous donations with local education: 1987–1989. Transfusion 1992;32:562–564.
Williamson KR, Taswell HF. Avoiding the hazards of homologous blood transfusion, and other advantages of autologous blood transfusion and hemotherapy. In: Taswell, HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991:22–52.
Kruskall MS. Autologous blood collection and transfusion in a tertiary-care center. In: Taswell HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991;54.
Toy PT, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery: a national multicenter study. N Engl J Med 1987;316:517–520.
Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802–812.
Goldfinger D, Haimowitz M, Aubuchon JP, et al. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Pro, Con. Transfusion. 1984;34(1):75 –83.
Birkmeyer JD, Goodnough LT, Aubuchon JP, et al. The cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thor Surg. 1994;57:161–169.
Dodrill FD, Marshall N, Nyboer J, et al. The use of the heart-lung apparatus in human cardiac surgery. J Thorac Surg 1957;33(1):60 –73.
Garcia E, Zamora R. Auto transfusion in elective thoracic operations: a preliminary report. Philippine J Surg Specialties 1964;18:33–38.
Ascari WQ, Jolly PC, Thomas PA. Autologous blood transfusion in pulmonary surgery. Transfusion 1968;8:111–115.
Daggett WM, Gada PH, Leape LL, et al. Autologous blood transfusion in pulmonary surgery. J Thorac Cardiovasc Surg 1970;59:546–550.
Newman MM, Hamstra R, Block M. Use of banked autologous blood in elective surgery. JAMA 1971;218(6):861 –863
Cuello L, Vasquez E, Rios R, et al. Autologous blood transfusion in thoracic and cardiovascular surgery. Surgery 1967;62(4):814 –818.
Kickler TS, Spivak JL. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1988;260(l):65–67.
Verska J J, Larson NL. Autologous transfusion in cardiac surgery: a case report of a patient with a rare antibody. Transfusion 1973;13(4):219–220.
Lubin J, Greenberg JJ, Yahr WZ, et al. The use of autologous blood in open-heart surgery. Transfusion 1974;14(6):602–607.
Cove H, Matloff HJ, Sherbcoe R, et al. Autologous blood transfusion in coronary artery bypass surgery. Transfusion 1976;16(3):245–248.
Fleming AW, Green DC, Radcliffe JH, et al. Development of a practical autologous transfusion program. Am Surg 1977;39:194–801.
Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially high risk patients. Transfusion 1983;23:229–232.
Kruskall MS, Glazer EE, Leonard SC, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986;26:335–340.
Love TR, Hendren WG, O’Keefe DD, et al. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987;43:508–512.
Owings DV, Kruskall MS, Thurer RL, et al. Autologous blood donations prior to elective cardiac surgery: safety and effect on subsequent blood use. JAMA 1989;262(14):1963–1968.
Britton LW, Eastlund T, Dziuban SW, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989;47:529–532.
Achenbach H, Tanzeem A, Saggau W, et al. Blood use reduction by predonation—how effective is it? In: Friedel N, Hetzer R, Royston D, eds. Blood Use in Cardiac Surgery. New York: Springer-Verlag, 1991;171–173.
Watanabe Y, Katsuo F, Konoshi T, et al. Autologous blood transfusion with recombinant human erythropoietin in heart operations. Ann Thorac Surg 1991;51:767–772.
Levine EA, Gould SA, Rosen AL, et al. Perioperative recombinant human erythropoietin. Surgery 1989;106(2):432.
Goodnough LT, Rudnick S, Price TH. Increased preoperative collection of autologous blood with recombinant erythropoietin therapy. N Engl J Med 1989;31:1163–1168.
Kulier A, Gombotz H, Fuchs G, et al. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anest Analg 1993;76:102–106.
Watanabe Y, Katsuo F, Naruse Y, et al. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg 1992;54:479–484.
Konoshi T, Ohbayashi T, Kaneko T, et al. Preoperative use of erythropoietin for cardiovascular operations in anemia. Ann Thor Surg. 1993;56:101–103.
D’Ambra MN, Lynch KE, Boccagno J, et al. The effect of perioperative administration of recombinant human erythropoietin (r-HuEPO) in CABG patients: a double blind, placebo-controlled trial. Anesthesiology 1992;77(3a):A159.
Dzik WH, Fleisher AG, Ciavarella D, et al. Safety and efficacy of autologous blood donation before elective valve operation. Ann Thorac Surg 1992;54:1177–1181.
Goldfinger D, Capon L, Czer L, et al. Safety and efficacy of preoperative donation of blood for autologous use by patients with end-stage heart or lung disease who are awaiting organ transplantation. Transfusion 1993;33:336–340.
Klapper E, Pepkowitz SH, Czer L, et al. Confirmation of the safety of autologous blood donation by patients awaiting heart or lung transplantation. J Thorac Cardiovasc Surg 1995;110:1594–1599.
Sandrelli L, Pardini A, Lorusso, et al. Impact of autologous blood predonation on a comprehensive blood conservation program. Ann Thorac Surg 1995;59:730–735.
Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 1991;115(1):28–35.
Robblee JA, Crosby E. Transfusion medicine issues in the practice of anesthesiology. Transfus Med Rev. 1995;9(l):60–78.
Masuda M, Kawachi Y, Inaba S, et al. Preoperative autologous blood donations in pediatric cardiac surgery. Ann Thorac Surg 1995;60:1694–1697.
Silvergleid AJ. Safety and effectiveness of predeposit autologous transfusions in preteen and adolescent children. JAMA. 1987;257(24):3403–3404.
Holland PV, Schmidt PH, eds. Standards for Blood Banks and Transfusion Services. 13th ed. Arlington VA: American Association of Blood Banks, 1989.
Schmidt PJ. Blood donation by the healthy elderly. Transfusion 1991;31(8):681–682.
Garry PJ, Vanderjagt DJ, Wayne SJ, et al. A prospective study of blood donations in healthy elderly persons. Transfusion 1991;31:686–692.
Haugen RK, Hill GE. A large-scale autologous blood program in a community hospital. A contribution to the community blood supply. JAMA 1987;257:1211–1214.
Mann M, Sacks HJ, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially “high risk” patients. Transfusion 1983;23:229–232.
Simon TL, Rhyne SJ, Wayne SJ, et al. Characteristics of elderly blood donors. Transfusion1991; 31: 693 – 697.
Ko W, Krieger KH, Lazenby WD, et al. Coronary bypass grafting in 100 consecutive octogenarian patients: a multicenter analysis, J Thorac Cardiovasc Surg 1991;102(4):532–538.
Simon TL, Smith KJ. The issues in autologous transfusion. Hum Pathol1989; 20 (1): 3 – 5.
Beutler E. Liquid preservation of red cells. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. Philadelphia: Williams and Wilkins, 1996: 58.
Helm RE, Gold JP, Rosengart TK, et al. Erythropoietin in cardiac surgery. J Cardiac Surg 1993;8:579–606.
Walker RH, ed. American Association of Blood Banks Technical Manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993;494.
Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 1990;115:28–35.
Coleman DH, Stevens DR, Doge HT, et al. Rate of blood regeneration after blood loss. Arch Intern Med 1953;92:341–349.
Levine E, Rosen A, Sehgal L, et al. Accelerated erythropoiesis: the hidden benefit of autologous donation. Transfusion 190;30:295–297.
Axelrod FB, Pepkowitz SH, Goldfinger D. Establishment of a schedule of optimal preoperative collection of autologous blood. Transfusion 1989;29:677–680.
Kruskall MS. Autologous blood collection and transfusion in a tertiary-care facility. In: Taswell HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991;60.
Popovsky MA, Aubuchon JP. Autologous blood donation in “high-risk” patients. Transfusion 1992;32(7):689.
Adegboyega PA, Patten ED. A review of presurgical autologous donation by high risk patients. Trans Mod Rev 1994;8(3):200–209.
Speiss BD, Sassetti R, McCarthy RJ, et al. Autologous blood donation: hemodynamics in a high risk population. Transfusion 1992;32:17–22.
Walker RH, ed. American Association of Blood Banks Technical Manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993: 401.
Kruskall MS. Autologous blood collection and transfusion in a tertiary-care center. In: Taswell HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991;58.
Silvergleid AJ. Preoperative autologous donation: what have we learned? Transfusion 1991;31(2):99–101.
Kruskall MS. Autologous blood collection and transfusion in a tertiary-care center. In: Taswell HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991;68.
Myhre BA. Crossing over of autologous and directed donor blood. Ann Clin Lab Sci 1992;22(5):343–352.
Yomtovian RA, Schrank JY, Betts YM, Kepner JL. Transfusion of previously donated blood in a community hospital. In: Taswell HF, Pineda AA, eds. Autologous Transfusion and Hemotherapy. Boston: Blackwell Scientific, 1991;87.
Valeri CR. Frozen red blood cells. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. Philadelphia: Williams and Wilkins. 1996: 61 – 66.
Silvergleid AJ. Autologous and designated donor programs. In: Petz LD, Swisher SN, Kleinman S, Spence RK, Strauss RG, eds. Clinical Practice of Transfusion Medicine. New York: Churchill Livingstone. 1996:287.
Page PL. Controversies in transfusion medicine. Directed donations: con. Transfusion 1989;29(1):65–70.
Schreiber GB, Busch MP, Kleinman SH, et al. The role of transfusion: transmitted viral infections. N Engl J Med 1996;334:1685–1690.
Jugli T, Takashi K, Shibata T, et al. Post-transfusion graft vs host disease in immunocompetent patients after cardiac surgery in Japan. N Engl J Med 1989;321:56.
Thaler M, Shamiss A, Orgad S, et al. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft vs host disease after open heart surgery. N Engl J Med 1989;321:25.
Klein HG. Standards for Blood Banks and Transfusion Services. 16th ed. Bethesda, MD: American Association of Blood Banks, 1994.
Goldfinger D. Directed blood donations: pro. Transfusion 1989;29(1):70–74.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Helm, R.E., Krieger, K.H. (1998). Preoperative Autologous and Directed Blood Donation. In: Krieger, K.H., Isom, O.W. (eds) Blood Conservation in Cardiac Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2180-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2180-7_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-94908-6
Online ISBN: 978-1-4612-2180-7
eBook Packages: Springer Book Archive